Malignant Hemangiopericytoma Arising in Neurofibromatosis: A Case
Report with Histological, Immunohistochemical and Ultrastructural
Studies by Wang, Jun et al.
Sarcoma (1999) 3, 135± 139
CASE REPORT
Malignant hemangiopericytoma arising in neuro® bromatosis: a case
report with histological, immunohistochemical and ultrastructural
studies
JUN WANG,
1 HERNAN VARGAS,
2 KARL GAAL,
1 XIA WANG
1 & SHI-KAUNG PENG
1
Departments of
1Pathology and
2Surgery, Harbor-UCLA Medical Center, University of California Los Angeles, School of
Medicine, 1000W. Carson Street,Torrance, CA 90509, USA
Abstract
Subject. A 27-year-old Hispanic male with clinical manifestation of neuro® bromatosis type 1 developed chronic constipa-
tion and urination difficulty along with recently increased abdominal bloating and anorexia. He also noted 40 lbs weight loss
over period of 1 year. Physical and radiographic examinations revealed a large mass in the right pelvic fossa.
Results. The surgically removed tumor was demonstrated, histologically, immunohistochemically, and ultrastructurally, to
be a malignant hemangiopericytoma.
Discussion. Although non-neurogenic tumors associated with neuro® bromatosis have been reported in these patients, only
one hemangiopericytoma case has been found in the English literature.We report here another case of this rare malignant
hemangiopericytoma in a patient with neuro® bromatosis.
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Introduction
Neuro® bromatosis (NF), or von Recklinghausen’s
disease, is an autosomal dominant disorder
characterized by multiple cafe-au-lait spots,
cutaneous neuro® bromas, and skeletal abnormali-
ties, which may also be associated with various
neurogenic malignancies.
1 Although rare, other
non-neurogenic sarcomas, such as osteosarcoma,
chondrosarcoma, liposarcoma, rhabdomyosar-
coma, and angiosarcoma, have been reported in
association with NF.
2± 4 In a search of the English
literature, we could only ® nd one case of a solitary
hemangiopericytoma arising in the ileum of a patient
with von Recklinghausen’s disease.
5 Hemangioperi-
cytoma is an uncommon tumor derived from
vascular pericytes and usually presents as a deep-
seated mass in the retroperitoneum, pelvic fossa,
lower limbs, orbital or sinonasal regions, or rarely
the deep subcutis.
6 We report here a case of
malignant hemangiopericytoma arising in pelvic
fossa of a patient with NF-1.The histological, immu-
nohistochemical, and ultrastructural features of
hemangiopericytoma, as well as its differential
diagnosis from other tumors with hemangio-
pericytoma-like pattern arising in patients with
NF-1, are also reviewed.
Patient
Clinical history
A 27-year-old Hispanic male with NF-1 since birth
presented with a 6-month history of chronic constipa-
tion and urination difficulty along with recently
increased abdominal bloating and anorexia. He also
noted 40 lbs weight loss over period of 1 year,
occasional nausea and vomiting, and occasional hema-
tochezia. He denied any hematemesis. His past
medical history was signi® cant for neuro® broma-
tosis, type 1. The past surgical history included
excision of right leg neuro® broma 1 month previ-
ously, sciatic nerve schwannoma 1 year previously,
and biopsied neuro® broma of the right eyebrow 10
years previously. Family history revealed that mother
and uncle had cafe-au-lait spots but without neuro® -
bromatosis.
Physical examination revealed a thin Hispanic male
with multiple neuro® bromatous nodules on scalp,
trunk, and extremities. Cafe-au-lait spots were
observed on the right neck area but no Lisch spots
were found. A large palpable right pelvic mass was
found displacing the rectum anteriorly and medially
on abdominal and rectal examination. The Guaiac
test was positive. Right foot drop was noted.
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imaging (MRI) revealed a large mass in the right
pelvic fossa (Fig. 1A).The patient underwent explora-
tory laparotomy and was found to have a large solitary
tumor in the right pelvic fossa, which involved the
internal iliac vessels and compressed the sacral plexus.
The tumor was separated from the sacral nerves and
removed surgically. The neurological de® cit of the
right foot improved slightly after surgery.
Material, methods and results
The tumor was sectioned extensively and the
specimen was processed according to a standard
histological method. Immunohistochemical staining
was performed using a universal biotin± streptavidin
peroxidase system (Vector Laboratories, Inc., Burlin-
game) with commercially available antibodies. The
antibodies used were against cytokeratin CAM5.2
(Becton-Dickinson, San Jose, CA) and AE1/AE3
Fig. 1. (A) Magnetic resonance imaging showed a large pelvic mass displacing rectum medially and anteriorly. (B) Bisected tumor
mass revealed a variegated tan light yellow to tan brown cut surface with extensive necrosis, focal hemorrhage and gelatinous degenera-
tion.
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IN), a -actin (Sigma, St. Louis, MO), actin (Enzo
Diagnostic, Inc., Syosset, NY), desmin (Dako),
myoglobin (Dako), collagen IV (Dako), factor XIIIa
(Calbiochem, San Diego, CA), vimentin (Sigma),
KP-1 (Dako), S-100 (Dako), chromogranin (Dako),
NSE (neural speci® c enolase) (Dako), synaptophysin
(Dako), Ulex europaeus I lectin (Dako), factor VIII
(Dako), CD34 (Becton-Dickinson), p53 (Dako),
HLA-DR (Coulter, Miami, CA), Leu-7 (Becton-
Dickinson) and LCA (leukocyte common antigen)
(Becton-Dickinson).Tissue was also taken and ® xed
in 2.5% glutaraldehyde, and processed according to
standard method for electron microscopy.
Gross pathology
The surgically removed tumor was a circumscribed
mass with pseudocapsule, measuring 113 10.53 10 cm,
weighing 510 g, and revealing a variegated light yellow
to tan brown cut surface with extensive yellow
discoloration, focal hemorrhage and gelatinous
degeneration (Fig. 1B).
Microscopic pathology
The tumor mass consisted of tightly packed spindle-
shaped cells surrounding rami® ed thin-walled
endothelium-lined vascular channels with
characteristic `antler’ or `staghorn’ con® guration (Fig.
2). The neoplastic cells had round to oval to slightly
angulated nuclei with clumped chromatin and a
moderate amount of cytoplasm with ill-de® ned cell
borders. Mitotic ® gures were frequently seen with an
average of 30 mitoses/10 high power ® elds, including
abnormal ones. Other areas of the tumor revealed
extensive necrosis and pseudocapsulation, as well as
focal hyaline degeneration.No nerve bundles or trunks
were seen in or adjacent to the tumor. Reticulin stain
showed that reticular ® bers surrounded each
individual neoplastic cell, characteristic of hemangi-
opericytoma (Fig. 3). Neoplastic cells were also
present at the inked specimen margins.
Immunohistochemistry
Cell marker study using the immunoperoxidase
method revealed that the neoplastic cells were posi-
tive for vimentin, factor XIIIa, CD34, HLA-DR, and
focally positive for desmin, actin, and myoglobin.
These ® ndings were consistent with hemangiopericy-
toma. Approximately one-third of the tumor cells
showed positive nuclear stain by anti-p53 antibody.
Tumor cells were negative for S-100, chromogranin,
NSE, synaptophysin, Leu-7, precluding its neuro-
genic origin. There was also no reactivity with
antibodies against cytokeratin, Ulex europaeus I lectin,
factor VIII, KP-1 or a -actin.
Electron microscopy
Ultrastructurally, the tumor cells were closely apposed
and spindle-shaped, with large round to oval to slightly
angulated nuclei and pale-staining cytoplasm
Fig. 2. Histological section of the tumor mass showing tightly packed spindle-like cells surrounding ramifying thin-walled endothelium-
lined vascular channels with typical `antler’ or `staghorn’ con® guration (H & E, 1803 ).
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ribosomes, rod-shaped or oval mitochondria, and
small bundles of micro® laments. These features are
seen in the pericytes. Occasionally, there were myoid
cells or myopericytes containing bundles of micro® la-
ments with condensed small fascicles, which were
intermediate in appearance between pericytes and
smooth muscle cells, and may also explain focal
desmin and actin expression. Pinocytotic vesicles were
also observed. More characteristically, a distinct
occasionally multilayered basal lamina was seen
surrounding individual tumor cells. These ® ndings
were consistent with hemangiopericytoma. In addi-
tion, there was no evidence of dendritic processes
characteristic of neurogenic tumors.
Follow-up
After discharge the patient was lost to follow-up for 2
months. He returned to the oncology service with a
complaint of abdominal pain. CT scan revealed a
new left lower peritoneal mass. Five cycles of
combined chemotherapy consisting of vincristine,
adriamycin, etoposide and ifosiphamide were
administered. Follow-up CT scan revealed
approximately 60% shrinkage of the mass.The patient
is currently undergoing radiation therapy.
Comment
Neuro® bromatosis-1 (NF-1), or von Reckling-
hausen’s disease, is an autosomal dominant disorder
affecting 1 in 3000 live births, and is often associated
with dermal tumors of neural origin.
1 In addition to
cutaneous tumors, patients with NF-1 may have
solitary deep tumors including non-neurogenic
sarcomas, gastrointestinal ganglioneuro® bromatosis,
meningiomas, ependymomas and occasionally may
show malignant transformation within a
neuro® broma.
2± 5,7,8 Konishi et al. described a case of
neuro® bromatosis patient with an unusual malignant
schwannoma which had a predominant
hemangiopericytoma-like arrangement, and also
contained foci of rhabdomyosarcomatous and angi-
osarcomatous differentiation.
7 A hemangiopericy-
toma and a plexiform neuro® broma present in the
same tumor of a patient with NF was also reported
by Aduana et al.
8 However, the association of solitary
hemangiopericytoma with NF is extraordinarily rare.
In 1992 Neilly and colleagues reported the ® rst case
of a 2.5-cm hemangiopericytoma arising in the ileum
in a patient with von Recklinghausen’s disease.
5 We
describe here another case of malignant hemangi-
opericytoma in a 27-year-old man with NF-1.
Since the morphology of hemangiopericytoma-
like pattern or arrangement can be seen focally in a
variety of tumors including benign and malignant
® brous histiocytoma, synovial sarcoma, mesen-
chymal chondrosarcoma, nerve sheath tumors, cellular
hemangioma, glomus tumor, and leiomyosarcoma,
differentiation of hemangiopericytomas from these
tumors is necessary, particularly from the ® rst four
entities.
1,6A combination of histological, immunohis-
tochemical, and ultrastructural studies on multiple
sections will help to differentiate hemangiopericy-
toma from those tumors mimicking its pattern. If a
tumor shows a consistent hemangiopericytoma
(uniform cellularity and vascular) pattern throughout
Fig. 3. Reticulin stain showing that reticular ® bers surround each individual neoplastic cells (1803 ).
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surrounding the individual tumor cells, and is nega-
tive for muscle, nerve sheath, and epithelial markers,
but positive for pericyte markers, such as CD34 and
factor XIIIa, etc., the diagnosis of hemangiopericy-
toma can be established in most cases.
6 As in the
present case, the tumor revealed not only a uniform
hemangiopericytoma pattern throughout the entire
mass, but a consistent immunohistochemical and
ultrastructural characterization of hemangiopericy-
toma as well. There was no evidence of any neuro-
genic differentiation.
The NF-1 gene, belonging to the family of tumor
suppressor genes, has been mapped to chromosome
17q11.2, encoding a protein, neuro® bromin, which
down-regulates the function of the p21 ras oncopro-
tein, and NF-1 is associated with deletions, inser-
tions or mutation in the NF-1 gene region.
9 Various
abnormalities on chromosome 17 but outside the
NF-1 gene region, possibly involving the p53, have
been demonstrated.
10 In the present case we also
demonstrated p53 positivity in about one-third of the
tumor cells.The exact mechnism(s) of the malignant
transformation or tumor progression or the tumori-
genesis of non-neurogenic tumors in neuro® broma-
tosis 1 is not yet fully understood.
In summary, we described a 27-year-old male with
NF-1 who developed a malignant hemangiopericy-
toma in the pelvis.The case reported here serves as a
reminder, especially for surgical pathologists, that
although extremely rare hemangiopericytoma may
occur in patients with NF and it should be included
in the differential diagnosis along with other
non-neurogenic sarcomas, particularly when a
histology of hemangiopericyte-like pattern is
encountered in solitary tumors in these patients.
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